TORONTO, Nov. 1, 2018 /CNW/ - Pure Global Cannabis
Inc. (TSX.V:PURE; OTC: PRCNF; FRA:1QS) (the "Company" or
"Pure Global" or "PURE"), an integrated,
growth-oriented life sciences cannabis company, through its
subsidiary PureSinse Inc. ("PureSinse"), is pleased to
announce that it has made three new hires to help with company's
operations and the production of expanded PureSinse offerings:
Sandra Couto as Clinical Affairs
Lead, Cheryl Pim as Director of New
Product Development, and Joseph Choi
as Controller.
Sandra, Cheryl, and Joseph will serve as integral members of the
senior leadership team. Their skills and expertise will become
vital to the operations and further development of the company's
initiatives and products.
Pure Global's new Clinical Affairs Lead, Sandra Couto, has been a driving force in the
Canadian pharmaceutical sector for more than twenty years. Couto, a
trained pharmacist, has held senior positions at University Health
Network, Schering Plough, Janssen
Ortho, Solvay, Wyeth Ayerst,
and Dupont, having worked in product management, sales, clinical
trials, and stakeholder relations. She will drive the clinical and
scientific objectives of Pure Global's investigational and medical
partnership programs. Sandra will also build a cross-functional
clinical portfolio of relationships internally and with external
partners.
Cheryl Pim joins Pure Global as
the Director of New Product Development. She is an award-winning
senior marketing and sales leader, product developer, and strategic
planner having held senior positions for Abbott, Janssen-Ortho,
Allergan, and Astellas. Cheryl will lead and coordinate the design,
launch and management of a range of pharmaceutical, cosmetic, and
health and wellness products. She will use her experience in
product design and marketing to create unique products in
categories where Pure Global can take a leadership position.
Joseph Choi brings a strong
background in finance to the role of Controller at Pure Global. He
has more than five years' experience as a financial professional in
the cannabis industry. In his position, Choi will report to the
Chief Financial Officer, add strategic vision, and be instrumental
in deploying comprehensive and scalable corporate accounting and
financial management systems. Joseph has experience working with
publicly traded licensed producers of cannabis and will ensure
timely and accurate accounting and preparation of financial reports
across all business units.
"I am thrilled to be adding such talented individuals to our
high-caliber team and adding significant bandwidth to our clinical
and product development capabilities," said Malay Panchal, CEO of
Pure Global. "This will enhance and expedite Pure Global's ability
to deploy a range of pharmaceutical, nutraceutical, and health
& wellness products to meet the needs of the Canadian and
growing international markets."
About Pure Global Cannabis
Pure Global Cannabis Inc. (TSX.V:PURE; OTC:PRCNF; FRA:1QS) is an
innovation-based cannabis Company led by experienced pharma,
biotechnology, horticultural, consumer packaged goods (CPG), and
supply chain experts. The Company's wholly owned subsidiary,
PureSinse Inc., is a licensed producer under the Cannabis Act,
2017. The Company's Brampton
campus houses facilities for vertically farmed cultivation,
R&D, extraction, manufacturing, and distribution. PURE will
produce branded and white-labeled cannabis products for the
medical, pharmaceutical, wellness, health & beauty, natural
health, food & beverage, and recreational legal markets with
uniquely formulated and purified concentrates. The Company is using
the Canadian market as a springboard to develop and manufacture
GMP-compliant cannabis products for international sale and
distribution with a goal to become one of the most trusted premium
international cannabis brands.
To register to Pure Global's mailing list, please visit
www.pureglobal.com. Follow @pureglobalcanna on Twitter and Facebook
and @pureglobalcannabis on Instagram.
FORWARD-LOOKING STATEMENTS
This news release contains certain forward-looking statements,
including, but not limited to, statements about Pure Global's
future plans and intentions. Wherever possible, words such as
"may", "will", "should", "could", "expect", "plan", "intend",
"anticipate", "believe", "estimate", "predict" or "potential" or
the negative or other variations of these words, or similar words
or phrases, have been used to identify these forward-looking
statements. These statements reflect management's current beliefs
and are based on information currently available to management as
at the date hereof.
Forward-looking statements involve significant risk,
uncertainties and assumptions. Many factors could cause actual
results, performance or achievements to differ materially from the
results discussed or implied in the forward-looking statements.
These factors should be considered carefully and readers should not
place undue reliance on the forward-looking statements. Although
the forward-looking statements contained in this news release are
based upon what management believes to be reasonable assumptions,
Pure Global cannot assure readers that actual results will be
consistent with these forward-looking statements. These
forward-looking statements are made as of the date of this news
release, and Pure Global assumes no obligation to update or revise
them to reflect new events or circumstances, except as required by
law.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSXV)
accepts responsibility for the adequacy or accuracy of this
release.
SOURCE Pure Global Cannabis Inc.